Redesign’s team, which consists of about 300 researchers, assembles, brands and launches healthcare startups.
The latest funding will go toward Redesign’s operations and platform.
Hemant Taneja, General Catalyst CEO and managing director also joined Redesign’s board, with CVS Health Ventures, UPMC Enterprises, TriplePoint Capital and Samsung Next also participating in the round.
In addition to investing, CVS Ventures, General Catalyst and UPMC Enterprises entered into innovation agreements with Redesign Health.
This means the companies can use Redesign’s platform tools, technologies and insights to help build and support businesses.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
